News Story: Full Text
Sponsored By
Gamma Tiles
Please Click On The Above Banner For More Details
Braintumor Website

 

Neurocrine Biosciences to Present at the CIBC World Markets Twelfth Annual Health Care Conference with Simultaneous Webcast (PR Newswire) ... largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis,... - Nov 05 4:13 PM ET



Website: http://biz.yahoo.com/prnews/011105/lam121_1.html

Posted on: 11/05/2001

"Yahoo - Neurocrine Biosciences to Present at the CIBC World Markets Twelfth Annual Health Care Conference with Simultaneous Webcast"
Yahoo! Finance Site Map[new] - Finance Home - Yahoo! - Help
PR Newswire

[ Latest Headlines | Market Overview | News Alerts ]


Related Quote
NBIX41+0.74
delayed 20 mins - disclaimer
Quote Data provided by Reuters

Monday November 5, 4:14 pm Eastern Time

Press Release

SOURCE: Neurocrine Biosciences, Inc.

Neurocrine Biosciences to Present at the CIBC World Markets Twelfth Annual Health Care Conference with Simultaneous Webcast

Company to Present Clinical Plan on Insomnia

SAN DIEGO, Nov. 5 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX - news) announced today that the Company will be presenting at the CIBC World Markets Twelfth Annual Health Care Conference being held in New York on Tuesday, November 6, 2001 at 12:30PM Pacific Time (3:30PM Eastern Time). The presentation will be simultaneously Webcast and can be viewed through a link provided via the Company's website at http://www.neurocrine.com.

Gary Lyons, President and CEO of Neurocrine will discuss the Company's clinical plan for the insomnia program. If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600 and ask for Claudia Jones or Elizabeth Foster. The presentation will be archived for 30 days.

Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders.

Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.

Contact: Claudia Jones at 858-658-7600.

SOURCE: Neurocrine Biosciences, Inc.

Email this story - Most-emailed articles - Most-viewed articles


More Quotes and News:Neurocrine Biosciences Inc (NasdaqNM:NBIX - news)
Related News Categories: biotech, medical/pharmaceutical

Help


Copyright © 2001 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Copyright © 2001 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Questions or Comments?
"
Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740